Clinical trial Recruiting at 5 sites Interventional Ages 35 and up

Ziplyft™ for improved healing and satisfaction after blepharoplasty.

Official title: Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™

Run by Osheru Inc. · NCT07144761 · Data updated 2026-11-12

This study will test whether Ziplyft™, a tissue adhesive, helps adults 35 and older having blepharoplasty heal with less bruising, good symmetry, and higher patient and surgeon satisfaction.

More Blepharoplasty trials

Quick facts

Study typeInterventional
Ages35 Years and up
SexAll
Enrollment200 (estimated)
SponsorOsheru Inc.
Industry-sponsored
Locations5 sites (Miami, Florida and 4 other locations)
StatusRecruiting
StartedAugust 2025
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedAugust 27, 2025
Trial IDNCT07144761 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 35 years or older with excess eyelid skin who are willing to return for required follow-up visits and, if of childbearing potential, have a negative pregnancy test and use acceptable contraception are ideal candidates.

Probably not a fit

Patients with a current ptosis diagnosis, those younger than 35, those who cannot attend follow-up visits, or who are pregnant are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study uses Ziplyft™, a tissue adhesive, for wound closure in adults undergoing blepharoplasty and collects patient-reported outcomes and surgeon satisfaction. Key measured outcomes include bruising, symmetry, adhesive success for wound closure, and case time. Participants are adults aged 35 or older judged eligible for eyelid skin removal by the investigator and must attend planned preoperative and follow-up visits. The multi-site US study is conducted at participating ophthalmic centers in Florida, Minnesota, and Pennsylvania.

Why it matters

Potential benefit: If successful, Ziplyft could reduce bruising and case time while improving wound closure, cosmetic symmetry, and both patient and surgeon satisfaction after blepharoplasty.

How similar studies have gone: Tissue adhesives for skin closure have shown positive results in other settings, but specific clinical data on Ziplyft™ for blepharoplasty are limited and its use in this setting is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Provide signed written consent prior to participation in any study-related procedures.
2. Ability, comprehension, and willingness to follow study instructions, and likely to complete all study visits.
3. Male or female adults, ≥ 35 years old at the Preoperative Visit
4. Willing to return for required follow-up visits.
5. Subjects with excess eyelid skin are eligible to undergo the procedure in the opinion of the investigator.
6. Female subjects must be 1-year postmenopausal, surgically sterilized, or, if of childbearing potential, have a negative urine pregnancy test at the Preoperative Visit. Women of childbearing potential must use an acceptable form of contraception throughout the study. Acceptable methods include at least one of the following: intrauterine (intrauterine device), hormonal (oral, injection, patch, implant, ring), barrier with spermicide (condom, diaphragm), or abstinence.

Exclusion Criteria:

1. Subjects with a current Ptosis diagnosis
2. Subjects with a history of Graves' Disease
3. Subjects with Myasthenia Gravis
4. Subjects that in the opinion of the investigator are anatomically not conducive to using devices (e.g., heavy brow, severe hollowing of the upper eyelid, history of ocular or orbital trauma).
5. Subjects that have had any previous surgery eyelid or eyebrow region.
6. Use of anticoagulation therapy, including, but not limited to Aspirin, NSAIDS, Ibuprofen within 7 days and Xarelto, Warfarin, Enoxaparin, Plavix within 3 days prior to planned study procedure.
7. Active or recent (within 3 months) tobacco user
8. Allergy to adhesive glue
9. Participation in any study of an investigational, interventional product within 30 days prior to the Preoperative Visit or at any time during the study period.
10. Pregnant or nursing females.

Where it's running

  • Center for Excellence in Eye Care
    Miami, Florida, United States
    Recruiting
  • Vance Thompson Vision
    Alexandria, Minnesota, United States
    Recruiting
  • Eye Care Specialists
    Kingston, Pennsylvania, United States
    Recruiting
  • Vance Thompson Vision
    Sioux Falls, South Dakota, United States
    Recruiting
  • The Eye Centers of Racine and Kenosha, LTD
    Kenosha, Wisconsin, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.